Type / Class
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Shares outstanding
266,837,198
Total 13F shares
14,328,662
Share change
-1,648,661
Total reported value
$229,696,396
Price per share
$16.03
Number of holders
48
Value change
-$16,435,312
Number of buys
19
Number of sells
28

Security key

05280R100

Report period

Q2 2020

Institutions

48

Top holders

10

Top shareholders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Capital World Investors
13F
Company
1.1%
2,955,806
$17,705,000 31 Mar 2020
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.79%
2,095,127
$13,304,000 31 Mar 2020
13F
Tetragon Partners GP Ltd
13F
Company
0.74%
1,982,601
$11,876,000 31 Mar 2020
13F
Capital International Investors
13F
Company
0.46%
1,222,688
$7,324,000 31 Mar 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.29%
783,164
$4,691,000 31 Mar 2020
13F
JUPITER ASSET MANAGEMENT LTD
13F
Company
0.26%
705,356
$4,133,000 31 Mar 2020
13F
Alphabet Inc.
13F
Company
0.26%
699,352
$4,189,000 31 Mar 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.22%
581,704
$3,485,000 31 Mar 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.2%
545,455
$3,267,000 31 Mar 2020
13F
Artal Group S.A.
13F
Company
0.19%
500,000
$2,995,000 31 Mar 2020
13F
MARSHALL WACE, LLP
13F
Company
0.18%
485,229
$2,907,000 31 Mar 2020
13F
Cormorant Asset Management, LP
13F
Company
0.18%
479,988
$2,875,000 31 Mar 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.13%
335,422
$2,009,000 31 Mar 2020
13F
Alyeska Investment Group, L.P.
13F
Company
0.11%
306,857
$1,838,000 31 Mar 2020
13F
Granahan Investment Management, LLC
13F
Company
0.11%
301,725
$1,807,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
0.09%
226,867
$1,359,000 31 Mar 2020
13F
DAFNA Capital Management LLC
13F
Company
0.08%
219,800
$1,317,000 31 Mar 2020
13F
FMR LLC
13F
Company
0.08%
212,108
$1,271,000 31 Mar 2020
13F
Eversept Partners, LP
13F
Company
0.08%
210,013
$1,257,978 31 Mar 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.06%
160,496
$961,000 31 Mar 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
0.06%
156,773
$939,000 31 Mar 2020
13F
Point72 Asset Management, L.P.
13F
Company
0.05%
124,463
$746,000 31 Mar 2020
13F
Laurion Capital Management LP
13F
Company
0.04%
118,734
$711,000 31 Mar 2020
13F
Vident Investment Advisory, LLC
13F
Company
0.04%
111,832
$670,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
101,447
$608,000 31 Mar 2020
13F
Weiss Multi-Strategy Advisers LLC
13F
Company
0.02%
48,153
$288,000 31 Mar 2020
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.02%
44,559
$267,000 31 Mar 2020
13F
MPM BioImpact LLC
13F
Company
0.01%
39,740
$238,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.01%
38,388
$230,000 31 Mar 2020
13F
VIRTUS ADVISERS, LLC
13F
Company
0.01%
28,428
$170,000 31 Mar 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
24,223
$145,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
19,943
$119,000 31 Mar 2020
13F
Aperio Group, LLC
13F
Company
0.01%
18,317
$110,000 31 Mar 2020
13F
Squarepoint Ops LLC
13F
Company
0.01%
15,296
$92,000 31 Mar 2020
13F
Burrage Capital Management LLC
13F
Company
0.01%
15,006
$84,000 31 Mar 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
14,921
$89,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
0%
11,844
$71,000 31 Mar 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0%
10,333
$62,000 31 Mar 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
8,200
$46,000 31 Mar 2020
13F
CITIGROUP INC
13F
Company
0%
4,909
$29,000 31 Mar 2020
13F
Legal & General Group Plc
13F
Company
0%
4,623
$27,000 31 Mar 2020
13F
UBS Group AG
13F
Company
0%
3,233
$19,000 31 Mar 2020
13F
US BANCORP \DE\
13F
Company
0%
1,570
$10,000 31 Mar 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
631
$4,000 31 Mar 2020
13F
Lindbrook Capital, LLC
13F
Company
0%
616
$4,000 31 Mar 2020
13F
SIGNATUREFD, LLC
13F
Company
0%
516
$3,000 31 Mar 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
470
$3,000 31 Mar 2020
13F
Parallel Advisors, LLC
13F
Company
0%
323
$1,000 31 Mar 2020
13F
Cubist Systematic Strategies, LLC
13F
Company
0%
245
$1,000 31 Mar 2020
13F
Derivatives Exane
13F
Individual
0%
180
$1,078 31 Mar 2020
13F

Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q2 2020

As of 30 Jun 2020, Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,328,662 shares. The largest 10 holders included Capital World Investors, Polygon Management Ltd., SCHRODER INVESTMENT MANAGEMENT GROUP, Capital International Investors, MILLENNIUM MANAGEMENT LLC, Alphabet Inc., CITADEL ADVISORS LLC, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, and Cormorant Asset Management, LP. This page lists 48 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
50
Q2 2020 holders
48
Holder diff
-2
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .